Harry Penner

Harry Penner

Fortune : 103 816 $ au 30/06/2026

80 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mr. Harry H.
Penner
, Jr., is an Executive Chairman at New Haven Pharmaceuticals, Inc., a Chairman & Chief Executive Officer at Nascent BioScience LLC, a Chairman at Celldex Therapeutics, Inc. and an Executive Chairman at Prevention Pharmaceuticals, Inc. He is on the Board of Directors at Aria Neurosciences, Inc., CaroGen Corp., MAKScientific LLC, Neurovail, Inc. and Omax Health, Inc. Mr. Penner was previously employed as a Chairman by QCDx LLC, a Lead Director by Altus Pharmaceuticals, Inc., a Chairman & Chief Executive Officer by Nascent BioSciences Inc., an Independent Director by Melinta Subsidiary Corp., a Vice Chairman, President & Chief Executive Officer by Neurogen Corp., a President & EVP-North America by Novo Nordisk North America, Inc., an Executive Vice President by Novo Nordisk A/S, a Chairman by Affinimark Technologies, Inc., a Chairman by Celldex Therapeutics, Inc. (Old), a Chairman by Connecticut Board of Governors for Higher Education, a Chairman by Connecticut Technology Council, a Co-Chairman by Connecticut United for Research Excellence, Inc., a Chairman by RHEI Pharmaceuticals, Inc., and a Chairman by Virscio, Inc. He also served on the board at Immedica Pharma US, Inc., AVANT Immunotherapeutics, Inc., Connecticut Business & Industry Association, Genaissance Pharmaceuticals, Inc. and Ikonisys, Inc. He received his undergraduate degree from the University of Virginia, a graduate degree from Fordham University and a graduate degree from New York University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/06/2026 2 790 ( 0 % ) 103 816 $ 30/06/2026

Postes actifs de Harry Penner

SociétésPosteDébut
CELLDEX THERAPEUTICS, INC. Président 05/06/2025
Neurovail, Inc.
Directeur/Membre du Conseil -
Fondateur -
Nascent BioScience LLC
Directeur Général 01/01/2001
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Fondateur -
Fondateur 19/05/2011
Directeur/Membre du Conseil -

Anciens postes connus de Harry Penner

SociétésPosteFin
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Harry Penner

Formation de Harry Penner

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

31

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées31

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Connecticut Board of Governors for Higher Education

Commercial Services

Health Technology

Commercial Services

Novo Nordisk North America, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Nascent BioScience LLC

Health Technology

Neurovail, Inc.

Health Technology

  1. Bourse
  2. Insiders
  3. Harry Penner
🔇